GYNAZOLE-1 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gynazole-1, and when can generic versions of Gynazole-1 launch?
Gynazole-1 is a drug marketed by Padagis Israel and is included in one NDA.
The generic ingredient in GYNAZOLE-1 is butoconazole nitrate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butoconazole nitrate profile page.
Summary for GYNAZOLE-1
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 165 |
Clinical Trials: | 1 |
Patent Applications: | 1,009 |
DailyMed Link: | GYNAZOLE-1 at DailyMed |
Recent Clinical Trials for GYNAZOLE-1
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Perrigo Company | N/A |
Padagis LLC | N/A |
Pharmacology for GYNAZOLE-1
Drug Class | Azole Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for GYNAZOLE-1
US Patents and Regulatory Information for GYNAZOLE-1
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Israel | GYNAZOLE-1 | butoconazole nitrate | CREAM;VAGINAL | 200923-001 | May 18, 2012 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |